CNBX Pharmaceuticals Inc. Annual Operating Margin in % from 2016 to 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
CNBX Pharmaceuticals Inc. quarterly/annual Operating Margin history and growth rate from 2016 to 2024.
  • CNBX Pharmaceuticals Inc. Operating Margin for the quarter ending August 31, 2024 was -448 %, a 97.4% decline year-over-year.
  • CNBX Pharmaceuticals Inc. annual Operating Margin for 2024 was -448 %, a 97.4% decline from 2023.
  • CNBX Pharmaceuticals Inc. annual Operating Margin for 2023 was -227 %, a 97.7% increase from 2022.
  • CNBX Pharmaceuticals Inc. annual Operating Margin for 2022 was -9.86K %.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -448 -221 -97.4% Sep 1, 2023 Aug 31, 2024
2023 -227 +9.63K +97.7% Sep 1, 2022 Aug 31, 2023
2022 -9.86K Sep 1, 2021 Aug 31, 2022
2020 -42.5K -8.96K -26.7% Sep 1, 2019 Aug 31, 2020
2019 -33.6K +6.11K +15.4% Sep 1, 2018 Aug 31, 2019
2018 -39.7K -7.05K -21.6% Sep 1, 2017 Aug 31, 2018
2017 -32.6K -32.4K -12973% Sep 1, 2016 Aug 31, 2017
2016 -249 Sep 1, 2015 Aug 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.